MPR Weekly Dose 71 - Guidance for those fully vaccinated; A first in COVID-19 testing; Povidone Iodine and Bamlanivimab-Etesevimab examined; Delayed local vaccine reactions

<p><span style="font-weight: 400;">This week it's all COVID related news; There’s new CDC guidance for those who are vaccinated; A first over the counter test that doesn’t require a prescription; Nasopharyngeal povidone iodine and the combo of Bamlanivimab-Etesevimab is assessed; And there’s reports of vaccine local reactions.</span></p>